Avenue Therapeutics Inc. (NASDAQ: ATXI)
$3.57
+0.0800 ( +2.29% ) 3.4K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$3.57
Previous close
$3.49
Volume
3.4K
Market cap
$3.25M
Day range
$3.45 - $3.72
52 week range
$3.21 - $91.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Jan 08, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Dec 13, 2023 |
3 | Insider transactions | 2 | Nov 28, 2023 |
8-k | 8K-related | 12 | Nov 24, 2023 |
10-q | Quarterly Reports | 52 | Nov 13, 2023 |
8-k | 8K-related | 15 | Nov 13, 2023 |
8-k | 8K-related | 23 | Nov 02, 2023 |
8-k | 8K-related | 12 | Sep 28, 2023 |
8-k | 8K-related | 12 | Sep 27, 2023 |